// App-Quantinova.ai

: Myeloma-Specific Oncolytic Adenovirus Induces Significant Tumour Oncolysis In Vitro and In Vivo and Prevents Cell Line Regrowth

Researchers

Presenter

  • Georgia Rose Stewart

Principal Investigators

  • Simon Tazzyman

  • Darren Lath

  • Jenny Down

  • John A Snowden

  • Michelle Lawson

  • Munitta Muthana

  • Andrew D Chantry

Medical Centers

  • Faculty of Medicine Dentistry and Health, The Medical School, Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom

  • Department of Oncology & Metabolism, University of Sheffield, Sheffield, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Department of Oncology & Metabolism, University of Sheffield, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Syndecan-1

  • Translocator protein

Drug/Treatment

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved